Experimental stem cell injection targets autism Self-Harm
NCT ID NCT07433517
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This early-phase trial will test a new treatment called VGN-Ex05e, made from human embryonic stem cells, for children and teens with autism who have severe, treatment-resistant self-injury or aggression. The treatment is injected directly into a brain area linked to behavior. Only 6 participants will be enrolled, and the main goal is to check safety and tolerability, not effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
VGN-Ex05e (nerve cells from human embryonic stem cells)
What this could lead to
If it works, this could point toward a new way to reduce severe self-injury and aggression in some people with autism.
What could go wrong
This is a very early, tiny trial (6 people) focused on safety, not proof of benefit. The brain injection carries risks, and results may not apply to most people with autism.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••